Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,399,329 | 855,869 | 386,527 | 1,611,120 | 1,149,759 |
| Depreciation Amortization | 1,407,468 | 892,956 | 442,038 | 1,784,339 | 1,288,432 |
| Income taxes - deferred | 16,857 | 48,261 | -32,292 | 71,978 | 33,627 |
| Accounts receivable | 21,712 | -61,099 | -280,928 | -71,804 | -19,934 |
| Accounts payable and accrued liabilities | 20,307 | 19,449 | 16,257 | -40,164 | 105,685 |
| Other Working Capital | 1,597,075 | 1,454,063 | -112,450 | -13,941 | 65,497 |
| Other Operating Activity | -197,101 | -12,654 | 225,191 | -466,543 | -625,645 |
| Operating Cash Flow | $4,265,647 | $3,196,844 | $644,343 | $2,874,985 | $1,997,421 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -859,781 | -546,834 | -309,484 | -1,246,847 | -863,893 |
| Net Acquisitions | -166,519 | -106,035 | -35,082 | -2,433,459 | -2,188,764 |
| Purchase Of Investment | -35,241 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 32,127 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 1 | 0 |
| Investing Cash Flow | $-1,029,414 | $-652,869 | $-344,566 | $-3,680,305 | $-3,052,657 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 927,160 | 758,755 | 1,140,570 | 1,140,842 | 992,225 |
| Debt Issued | 2,465,739 | 1,392,036 | 13,971 | 3,876,102 | 1,767,906 |
| Debt Repayment | -1,800,901 | -1,168,153 | -627,333 | -2,483,046 | -1,766,430 |
| Common Stock Issued | 12,235 | 10,327 | 458 | 17,768 | 12,932 |
| Common Stock Repurchased | -427,840 | -402,989 | -238,427 | -671,772 | -516,476 |
| Dividend Paid | -410,518 | N/A | N/A | -728,901 | -394,355 |
| Other Financing Activity | -3,215,443 | -2,134,049 | -155,406 | -1,673,623 | -431,948 |
| Financing Cash Flow | $-2,449,568 | $-1,544,073 | $133,834 | $-522,629 | $-336,147 |
| Exchange Rate Effect | -95,860 | -29,051 | 4,723 | 53,491 | 78,580 |
| Beginning Cash Position | 1,178,028 | 1,109,604 | 1,111,720 | 2,403,108 | 2,385,943 |
| End Cash Position | 1,868,832 | 2,080,455 | 1,550,053 | 1,128,650 | 1,073,140 |
| Net Cash Flow | $690,804 | $970,851 | $438,333 | $-1,274,458 | $-1,312,803 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,265,647 | 3,196,844 | 644,343 | 2,874,985 | 1,997,421 |
| Capital Expenditure | -871,617 | -550,735 | -311,077 | -1,259,766 | -876,009 |
| Free Cash Flow | 3,394,030 | 2,646,109 | 333,266 | 1,615,219 | 1,121,412 |